Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Shanghai - Delayed Quote CNY

Shanghai Junshi Biosciences Co., Ltd. (688180.SS)

Compare
30.96
-0.99
(-3.10%)
As of 11:29:57 AM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,618,903
1,502,550
1,453,493
4,024,841
1,594,897
Cost of Revenue
589,578
667,290
526,282
1,258,187
372,531
Gross Profit
1,029,325
835,260
927,211
2,766,654
1,222,366
Operating Expense
2,977,215
3,287,276
3,643,474
3,359,361
2,890,784
Operating Income
-1,947,890
-2,452,016
-2,716,263
-592,707
-1,668,418
Net Non Operating Interest Income Expense
30,002
70,420
31,648
9,146
-9,113
Pretax Income
-1,998,948
-2,489,887
-2,675,202
-592,648
-1,669,461
Tax Provision
98,041
43,995
-93,107
135,533
-3,822
Net Income Common Stockholders
-1,930,894
-2,281,624
-2,386,067
-718,557
-1,665,639
Diluted NI Available to Com Stockholders
-1,930,894
-2,281,624
-2,386,067
-718,557
-1,665,639
Basic EPS
-1.97
-2.32
-2.60
-0.80
-2.02
Diluted EPS
-1.97
-2.32
-2.60
-0.80
-2.02
Basic Average Shares
985,177.99
985,302.17
917,465.17
892,659.69
824,816.64
Diluted Average Shares
985,177.99
985,302.17
917,465.17
892,659.69
824,816.64
Total Expenses
3,566,793
3,954,566
4,169,756
4,617,548
3,263,315
Net Income from Continuing & Discontinued Operation
-1,930,894
-2,281,624
-2,386,067
-718,557
-1,665,639
Normalized Income
-1,926,401.50
-2,274,649
-2,411,199.75
-804,444
-1,708,775.02
Interest Income
68,853
99,426
61,018
30,979
20,278
Interest Expense
38,851
29,006
29,370
21,833
29,391
Net Interest Income
30,002
70,420
31,648
9,146
-9,113
EBIT
-1,960,097
-2,460,881
-2,645,832
-570,815
-1,640,070
EBITDA
-1,960,097
-2,157,661
-2,352,178
-308,256
-1,488,708
Reconciled Cost of Revenue
589,578
667,290
526,282
1,258,187
372,531
Reconciled Depreciation
59,591
303,220
293,654
262,559
151,362
Net Income from Continuing Operation Net Minority Interest
-1,930,894
-2,281,624
-2,386,067
-718,557
-1,665,639
Total Unusual Items Excluding Goodwill
-5,990
-9,300
26,039
114,516
43,235
Total Unusual Items
-5,990
-9,300
26,039
114,516
43,235
Normalized EBITDA
-1,954,107
-2,148,361
-2,378,217
-422,772
-1,531,943
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,497.50
-2,325
906.25
28,629
98.98
12/31/2020 - 7/15/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2171.HK CARsgen Therapeutics Holdings Limited
16.520
-1.43%
 
2696.HK Shanghai Henlius Biotech, Inc.
27.300
-3.36%
 
9939.HK Kintor Pharmaceutical Limited
1.120
-6.67%
 
AVBP ArriVent BioPharma, Inc.
23.70
-2.79%
 
1548.HK GENSCRIPT BIO
12.660
-4.52%
 
ITOS iTeos Therapeutics, Inc.
7.00
-0.99%
 
6160.HK BeiGene, Ltd.
167.500
+3.65%
 
1801.HK INNOVENT BIO
41.300
-4.40%
 
ONC BeiGene, Ltd.
278.38
+7.48%
 
LEGN Legend Biotech Corporation
36.72
+0.52%